Intraocular injection of Clindamycin and Dexamethazone in the management of Toxoplasma infection of the retina
Not Applicable
- Conditions
- Health Condition 1: null- Toxoplasma retinitis
- Registration Number
- CTRI/2017/08/009443
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Applicable
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with active toxoplasma chorioretinitis
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Resolution of active inflammation, Improvement of visual acuityTimepoint: 3 Months
- Secondary Outcome Measures
Name Time Method Decreased macular thickness on OCT <br/ ><br>Drug adverse effectsTimepoint: 3 months